Using A Natural DNA Repair Process to Improve Genetic Medicines

Precision, safety, and durability are challenges for gene replacement and gene editing therapies. LogicBio Therapeutics says its GeneRide platform technology addresses these challenges by harnessing a natural DNA repair process. We spoke to Daniel Gruskin, chief medical officer of LogicBio, about the company’s platform technology, the advantages it provides, and the company’s lead experimental therapy for the rare metabolic condition methylmalonic acidemia.

Episode metadata supplied by the publisher feed · Published Jun 18, 2021

Embed this episode

Attribution link and audio player

What this episode covers

Daniel Gruskin, chief medical officer of LogicBio, discusses the company’s platform technology, the advantages it provides, and the company’s lead experimental therapy for the rare metabolic condition methylmalonic acidemia.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Using A Natural DNA Repair Process to Improve Genetic Medicines

0:00 26:34

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of RARECast?

This episode is 26 minutes long.

When was this RARECast episode published?

This episode was published on June 18, 2021.

Can I download this RARECast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!